Pharmaceutical News and Articles
NEW YORK, October 7, 2009– About 35% of the U.S. adult population uses social media for health and medical purposes in 2009, according to pharmaceutical and healthcare market research company Manhattan Research’s Cybercitizen Health™...
New Ad Campaign Scheduled for 2010 SEATTLE--(BUSINESS WIRE)--Oct 6, 2009 - Hydrogen Advertising has partnered with the Greater Washington Chapter of the National MS Society to handle creative duties for the organization on a pro bono basis. The...
Adjustments may be needed to achieve desired anticoagulant effect in some patients New Heparin to Ship Starting October 8 SILVER SPRING, Md., Oct. 1 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today alerted health...
ROCKVILLE, Md., Sept. 30, 2009--The U.S. Food and Drug Administration today announced the availability of the first draft guidance for industry on Risk Evaluation and Mitigation Strategies or REMS, which are required for certain drugs or...
Rockville, MD., Sept. 25, 2009--FDA notified healthcare professionals of an Early Communication regarding an ongoing review of safety issues with Exjade (deferasirox). New safety data suggests there may be a greater number of adverse events and...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Sep 25, 2009 - Merck & Co., Inc., issued the following statement today in response to the U.S. Food and Drug Administration's (FDA's) update on JANUVIA (sitagliptin) and JANUMET...
PR TO DEVELOP SUDDEN CARDIAC AWARENESS CAMPAIGN - Firm's Cardiology Expertise a Winning Factor - New York/Washington, D.C., September 24, 2009 – In a competitive review, Publicis Consultants | PR has been awarded a planning project for the...
ROCKVILLE, Md., Sept. 25, 2009--FDA notified healthcare professionals and patients of revisions to the prescribing information for Januvia (sitagliptin) and Janumet (sitagliptin/metformin) to include information on reported cases of acute...
ROCKVILLE, Md., Sept. 25, 2009--FDA issued a Public Health Alert to notify prescribers and pharmacists about potential dosing errors with Tamiflu (oseltamivir) for Oral Suspension. U.S. health care providers usually write prescriptions for liquid...
CEDAR KNOLLS, N.J., Sept. 22 /PRNewswire/ -- ScienceFirst is pleased to announce an expansion to its leadership team as a result of ScienceFirst's sustained annual growth. Robert Steen was recently named senior account director at ScienceFirst,...
Baer Consulting, an Award-Winning Communications Firm, Launches RxEd, a New Patient Education and Advocacy Relations Practice   Montclair, NJ – September 22, 2009 – Baer Consulting Inc., a boutique healthcare marketing and...
ROCKVILLE, Md., Sept. 22, 2009--FDA continues to receive reports of progressive multifocal leukoencephalopathy (PML) in patients receiving Tysabri. Tysabri was approved by the FDA for the treatment of relapsing forms of multiple sclerosis (MS)...
LONDON and SAN CARLOS, Calif., Sept. 21 /PRNewswire-FirstCall/ -- AstraZeneca and Nektar Therapeutics announced today that they have entered into an exclusive worldwide license agreement for two drug development programmes: NKTR-118, a late stage...
CAMP HILL, Pa.--(BUSINESS WIRE)--Sep 18, 2009 - Rite Aid Corporation (NYSE: RAD) announced today that Ernie Richardsen, a 17-year pharmacy industry veteran, has been promoted to Group Vice President, Pharmaceutical Purchasing and Clinical Services....
LONDON, September 18/PRNewswire/ -- London Genetics Limited, which expedites pharmacogenetic partnerships between the biopharmaceutical industry and London-based centres of excellence in genetics research, announces today several...
SEATTLE--(BUSINESS WIRE)--Sep 18, 2009 - ZymoGenetics, Inc. (NASDAQ:ZGEN) announced today that Dennis M. Miller, Ph.D. has been promoted to the position of Senior Vice President of Research and Preclinical Development and will serve as a member of...
India-Based ˜Hilleman Laboratories' to Operate on a Not-for-Profit Basis to Turn Innovative Science into Practical Solutions Altaf A. Lal, Ph.D. Named as CEO; Hilleman Laboratories to Extend Legacy of Maurice Hilleman, Ph.D., the Creator of...
ROCKVILLE, Md., Sept. 16, 2009--The U.S. Food and Drug Administration is telling manufacturers of the drug promethazine to include a boxed warning regarding the injectable form of the drug. The warning, under FDA’s authority to require safety...
Manhattan Research Specialist Segmentation Module Explores How Oncologists Use the Internet and Other Technologies for Professional Purposes and Treatment Decisions New York, September 16, 2009– Oncologists are more likely than the overall...
CHICAGO--(BUSINESS WIRE)--Sep 15, 2009 - Chicago-based strategic interactive advisory firm, Marcel Media today announced it's recent award win for their outstanding work with NorthShore University HealthSystem. Their implementation of web 2.0...
More...

Pharma Industry News Archive

2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

MedNotes
Advertisement

(web1)